Combined immunochemotherapy with reduced dose whole brain radiotherapy (WBRT) for newly diagnosed patients (pts) with primary CNS lymphoma (PCNSL)

被引：0
|
作者：
Shah, G
Lai, R
Yahalom, J
Correa, D
DeAngelis, L
Raizer, J
Schiff, D
LaRocco, R
Grant, B
Abrey, L
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] McMaster Univ, Hamilton, ON L8S 4L8, Canada
[3] Northwestern Univ, Chicago, IL 60611 USA
[4] Univ Virginia, Med Ctr, Charlottesville, VA 22903 USA
[5] Kentuckiana Canc Inst PLLC, Louisville, KY USA
[6] Univ Vermont, Burlington, VT 05405 USA
来源：
NEURO-ONCOLOGY | 2005年 / 7卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
340
引用
收藏
页码：368 / 368
页数：1
相关论文
共 50 条
  • [41] CHOD/BVAM CHEMOTHERAPY AND WHOLE-BRAIN RADIOTHERAPY FOR NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
    Laack, Nadia N.
    O'Neill, Brian Patrick
    Ballman, Karla V.
    O'Fallon, Judith Rich
    Carrero, Xiomara W.
    Kurtin, Paul J.
    Scheithauer, Bernd W.
    Brown, Paul D.
    Habermann, Thomas M.
    Colgan, Joseph P.
    Gilbert, Mark R.
    Hawkins, Roland B.
    Morton, Roscoe F.
    Windschitl, Harry E.
    Fitch, Tom R.
    Pajon, Eduardo R., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : 476 - 482
  • [42] High-dose methotrexate with or without rituximab in newly diagnosed primary CNS lymphoma
    Holdhoff, Matthias
    Ambady, Prakash
    Abdelaziz, Ahmed
    Sarai, Guneet
    Bonekamp, David
    Blakeley, Jaishri
    Grossman, Stuart A.
    Ye, Xiaobu
    NEUROLOGY, 2014, 83 (03) : 235 - 239
  • [43] HIGH-DOSE METHOTREXATE WITH OR WITHOUT RITUXIMAB IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA
    Chamberlain, Marc C.
    NEUROLOGY, 2015, 84 (07) : 758 - 759
  • [44] Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
    Julia Wendler
    Christopher P. Fox
    Elke Valk
    Cora Steinheber
    Heidi Fricker
    Lisa K. Isbell
    Simone Neumaier
    Jessica Okosun
    Florian Scherer
    Gabriele Ihorst
    Kate Cwynarski
    Elisabeth Schorb
    Gerald Illerhaus
    BMC Cancer, 22
  • [45] Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma
    Wendler, Julia
    Fox, Christopher P.
    Valk, Elke
    Steinheber, Cora
    Fricker, Heidi
    Isbell, Lisa K.
    Neumaier, Simone
    Okosun, Jessica
    Scherer, Florian
    Ihorst, Gabriele
    Cwynarski, Kate
    Schorb, Elisabeth
    Illerhaus, Gerald
    BMC CANCER, 2022, 22 (01)
  • [46] High-Dose Methotrexate, Rituximab, and Temozolomide (MRT) for Patients with Primary CNS Lymphoma (PCNSL).
    Gerstner, Elizabeth R.
    Hochberg, Fred H.
    Plotkin, Scott R.
    Eichler, April F.
    Batchelor, Tracy T.
    BLOOD, 2009, 114 (22) : 667 - 667
  • [47] Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial
    Ulrich Herrlinger
    Niklas Schäfer
    Rolf Fimmers
    Frank Griesinger
    Michael Rauch
    Heinz Kirchen
    Patrick Roth
    Martin Glas
    Michael Bamberg
    Peter Martus
    Eckhard Thiel
    Agnieszka Korfel
    Michael Weller
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1815 - 1821
  • [48] Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial
    Herrlinger, Ulrich
    Schaefer, Niklas
    Fimmers, Rolf
    Griesinger, Frank
    Rauch, Michael
    Kirchen, Heinz
    Roth, Patrick
    Glas, Martin
    Bamberg, Michael
    Martus, Peter
    Thiel, Eckhard
    Korfel, Agnieszka
    Weller, Michael
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (09) : 1815 - 1821
  • [49] A clinical variable-based predictive model of delayed clearance of high dose methotrexate (HDMTX) in patients (pts) with primary CNS lymphoma (PCNSL).
    Yuan, Yu
    Snyder, Brandy Strickland
    Russell, Greg B.
    Lesser, Glenn Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma
    Lin, Chia-Hsin
    Yang, Ching-Fen
    Yang, Huai-Che
    Fay, Li-Yu
    Yeh, Chiu-Mei
    Kuan, Ai-Seon
    Wang, Hao-Yuan
    Gau, Jyh-Pyng
    Hsiao, Liang-Tsai
    Chiou, Tzeon-Jye
    Chen, Po-Min
    Liu, Yao-Chung
    Ko, Po-Shen
    Liu, Jin-Hwang
    Liu, Chia-Jen
    JOURNAL OF CANCER, 2019, 10 (17): : 3958 - 3966
12345